Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 15.83 USD 0.06% Market Closed
Market Cap: 2B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Neogenomics Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Neogenomics Inc
Cash from Operating Activities Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Neogenomics Inc
NASDAQ:NEO
Cash from Operating Activities
$264k
CAGR 3-Years
-67%
CAGR 5-Years
-60%
CAGR 10-Years
-28%
Thermo Fisher Scientific Inc
NYSE:TMO
Cash from Operating Activities
$9.1B
CAGR 3-Years
-4%
CAGR 5-Years
13%
CAGR 10-Years
14%
Danaher Corp
NYSE:DHR
Cash from Operating Activities
$6.3B
CAGR 3-Years
-9%
CAGR 5-Years
9%
CAGR 10-Years
6%
Mettler-Toledo International Inc
NYSE:MTD
Cash from Operating Activities
$1B
CAGR 3-Years
5%
CAGR 5-Years
12%
CAGR 10-Years
10%
Agilent Technologies Inc
NYSE:A
Cash from Operating Activities
$1.8B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
7%
IQVIA Holdings Inc
NYSE:IQV
Cash from Operating Activities
$2.6B
CAGR 3-Years
-5%
CAGR 5-Years
16%
CAGR 10-Years
21%

See Also

What is Neogenomics Inc's Cash from Operating Activities?
Cash from Operating Activities
264k USD

Based on the financial report for Jun 30, 2024, Neogenomics Inc's Cash from Operating Activities amounts to 264k USD.

What is Neogenomics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-28%

The average annual Cash from Operating Activities growth rates for Neogenomics Inc have been -67% over the past three years , -60% over the past five years , and -28% over the past ten years .

Back to Top